US Patent Issued to Bristol-Myers Squibb on Jan. 20 for "Prodrugs in the modulation of interleukin" (American, Indian Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,782, issued on Jan. 20, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Prodrugs in the modulation of interleukin" was invented by Ryan M. Moslin (Princeton, N.J.), David S. Weinstein (San Diego), Thangeswaran Ramar (Hosur, India) and Murugaiah Andappan Murugaiah Subbaiah (Hosur, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "There are disclosed prodrugs of the compounds of the formula. The prodrugs are useful in the modulation of IL-12, IL-23 and/or IFNAlpha, by acting on Tyk-2 to cause signal transduction inhibition."

The patent was filed on July 14, 2020, under Application No. 17/627,169.

*For further information, including i...